Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults With Major Depressive Disorder, With or Without Anxious Distress

NCT07161700 is registered in ClinicalTrials.gov with Seaport Therapeutics as lead sponsor.

NCT NCT07161700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults With Major Depressive Disorder, With or Without Anxious Distress
Lead sponsor
Seaport Therapeutics
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
September 2, 2025
Completion date
May 31, 2027
Enrollment
360 (estimated)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd), major depressive disorder with anxious distress